(Q43931245)

English

In vivo evidence of immunological masking of the Vibrio cholerae O antigen of a hybrid Salmonella typhi Ty21a-Vibrio cholerae oral vaccine in humans

scientific article published on July 1, 1991

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

In vivo evidence of immunological masking of the Vibrio cholerae O antigen of a hybrid Salmonella typhi Ty21a-Vibrio cholerae oral vaccine in humans (English)

1 reference

10.1016/0264-410X(91)90039-9

https://api.crossref.org/works/10.1016/0264-410X(91)90039-9

6 November 2022

Vibrio cholerae

0 references

molecular medicine

1 reference

10.1016/0264-410X(91)90039-9

https://api.crossref.org/works/10.1016/0264-410X(91)90039-9

6 November 2022

Salmonella typhi

object named as

Salmonella typhi

1 reference

based on heuristic

inferred from title

author name string

LaBrooy JT

2

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

B. D. Forrest

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1716810

6 November 2022

J. T. LaBrooy

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1716810

6 November 2022

language of work or name

0 references

publication date

1 July 1991

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

full work available at URL

https://api.elsevier.com/content/article/PII:0264410X91900399?httpAccept=text/xml

1 reference

10.1016/0264-410X(91)90039-9

https://api.crossref.org/works/10.1016/0264-410X(91)90039-9

6 November 2022

https://api.elsevier.com/content/article/PII:0264410X91900399?httpAccept=text/plain

1 reference

10.1016/0264-410X(91)90039-9

https://api.crossref.org/works/10.1016/0264-410X(91)90039-9

6 November 2022

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

515-520

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Evaluation of a UDP-glucose-4-epimeraseless mutant of Salmonella typhi as a liver oral vaccine

1

1 reference

10.1016/0264-410X(91)90039-9

https://api.crossref.org/works/10.1016/0264-410X(91)90039-9

6 November 2022

A controlled field trial of live Salmonella typhi strain Ty 21a oral vaccine against typhoid: three-year results

3

1 reference

10.1016/0264-410X(91)90039-9

https://api.crossref.org/works/10.1016/0264-410X(91)90039-9

6 November 2022

Large-scale field trial of Ty21a live oral typhoid vaccine in enteric-coated capsule formulation

4

1 reference

10.1016/0264-410X(91)90039-9

https://api.crossref.org/works/10.1016/0264-410X(91)90039-9

6 November 2022

Identification of an intestinal immune response using peripheral blood lymphocytes.

5

1 reference

10.1016/0264-410X(91)90039-9

https://api.crossref.org/works/10.1016/0264-410X(91)90039-9

6 November 2022

Construction of a potential bivalent vaccine strain: introduction of Shigella sonnei form I antigen genes into the galE Salmonella typhi Ty21a typhoid vaccine strain

6

1 reference

10.1016/0264-410X(91)90039-9

https://api.crossref.org/works/10.1016/0264-410X(91)90039-9

6 November 2022

Safety and Antigenicity of Typhoid-Shigella sonnei Vaccine (Strain 5076-1C)

8

1 reference

10.1016/0264-410X(91)90039-9

https://api.crossref.org/works/10.1016/0264-410X(91)90039-9

6 November 2022

Colonization factor antigen II (CFA/II) of enterotoxigenic Escherichia coli: molecular cloning of the CS3 determinant

9

1 reference

10.1016/0264-410X(91)90039-9

https://api.crossref.org/works/10.1016/0264-410X(91)90039-9

6 November 2022

Live oral Salmonella vaccines: potential use of attenuated strains as carriers of heterologous antigens to the immune system

11

1 reference

10.1016/0264-410X(91)90039-9

https://api.crossref.org/works/10.1016/0264-410X(91)90039-9

6 November 2022

Immunogenicity of a candidate live oral typhoid/cholera hybrid vaccine in humans.

13

1 reference

10.1016/0264-410X(91)90039-9

https://api.crossref.org/works/10.1016/0264-410X(91)90039-9

6 November 2022

Safety, immunogenicity, and efficacy against cholera challenge in humans of a typhoid-cholera hybrid vaccine derived from Salmonella typhi Ty21a

14

1 reference

10.1016/0264-410X(91)90039-9

https://api.crossref.org/works/10.1016/0264-410X(91)90039-9

6 November 2022

Surface co-expression of Vibrio cholerae and Salmonella typhi O-antigens on Ty21a clone EX210

15

1 reference

10.1016/0264-410X(91)90039-9

https://api.crossref.org/works/10.1016/0264-410X(91)90039-9

6 November 2022

The serum polymeric IgA antibody response to typhoid vaccination; its relationship to the intestinal IgA response

16

1 reference

10.1016/0264-410X(91)90039-9

https://api.crossref.org/works/10.1016/0264-410X(91)90039-9

6 November 2022

The human humoral immune response to Salmonella typhi Ty21a.

17

1 reference

10.1016/0264-410X(91)90039-9

https://api.crossref.org/works/10.1016/0264-410X(91)90039-9

6 November 2022

Immunochemical quantitation of antigens by single radial immunodiffusion

19

1 reference

10.1016/0264-410X(91)90039-9

https://api.crossref.org/works/10.1016/0264-410X(91)90039-9

6 November 2022

Influence of gastric acidity on bacterial and parasitic enteric infections. A perspective

20

1 reference

10.1016/0264-410X(91)90039-9

https://api.crossref.org/works/10.1016/0264-410X(91)90039-9

6 November 2022

Effect of neutralization of gastric acid on immune responses to an oral B subunit, killed whole-cell cholera vaccine

21

1 reference

10.1016/0264-410X(91)90039-9

https://api.crossref.org/works/10.1016/0264-410X(91)90039-9

6 November 2022

Mucosal antitoxic and antibacterial immunity after cholera disease and after immunization with a combined B subunit-whole cell vaccine.

26

1 reference

10.1016/0264-410X(91)90039-9

https://api.crossref.org/works/10.1016/0264-410X(91)90039-9

6 November 2022

The Antigens of Vibrio cholerae Involved in the Vibriocidal Action of Antibody and Complement

27

1 reference

10.1016/0264-410X(91)90039-9

https://api.crossref.org/works/10.1016/0264-410X(91)90039-9

6 November 2022

Protection against lethality of E. coli endotoxin with "O" antiserum

28

1 reference

10.1016/0264-410X(91)90039-9

https://api.crossref.org/works/10.1016/0264-410X(91)90039-9

6 November 2022

Relationship of structure to function in bacterial endotoxins: serologically cross-reactive components and their effect on protection of mice against some gram-negative infections

31

1 reference

10.1016/0264-410X(91)90039-9

https://api.crossref.org/works/10.1016/0264-410X(91)90039-9

6 November 2022

O-antigenic chains of lipopolysaccharide prevent binding of antibody molecules to an outer membrane pore protein in Enterobacteriaceae

34

1 reference

10.1016/0264-410X(91)90039-9

https://api.crossref.org/works/10.1016/0264-410X(91)90039-9

6 November 2022

Effect of lipopolysaccharide structure on reactivity of antiporin monoclonal antibodies with the bacterial cell surface

35

1 reference

10.1016/0264-410X(91)90039-9

https://api.crossref.org/works/10.1016/0264-410X(91)90039-9

6 November 2022

Salmonella typhi vaccine strain in vitro; low infectivity in human cell line U937.

36

1 reference

10.1016/0264-410X(91)90039-9

https://api.crossref.org/works/10.1016/0264-410X(91)90039-9

6 November 2022

Immunoblot detection of class-specific humoral immune response to outer membrane proteins isolated from Salmonella typhi in humans with typhoid fever

37

1 reference

10.1016/0264-410X(91)90039-9

https://api.crossref.org/works/10.1016/0264-410X(91)90039-9

6 November 2022

Crossed immunoelectrophoretic analysis of anti-Salmonella typhi antibodies in sera of typhoid patients and carriers: demonstration of the presence of typhoid-specific antibodies to a non-O, non-H, non-Vi antigen

38

1 reference

10.1016/0264-410X(91)90039-9

https://api.crossref.org/works/10.1016/0264-410X(91)90039-9

6 November 2022

Protective antibody to endotoxin core: the emperor's new clothes?

42

1 reference

10.1016/0264-410X(91)90039-9

https://api.crossref.org/works/10.1016/0264-410X(91)90039-9

6 November 2022

Antibodies to lipid A: occurrence in humans

43

1 reference

10.1016/0264-410X(91)90039-9

https://api.crossref.org/works/10.1016/0264-410X(91)90039-9

6 November 2022

Identifiers

10.1016/0264-410X(91)90039-9

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43931245&oldid=1799579553"